对于心脏性休克并发症急性心肌梗塞的真实世界干预结果
John E Brush1,2, Ann M Harper1, Luke C Kohan1,2
1Sentara Health, Norfolk, VA, USA.
概括
与大动脉内气球逆脉冲 (IABP) 相比,急性心肌梗塞与心脏性休克 (AMICS) 的机械循环支持 (MCS) 显示死亡率和并发症风险更高. 在AMICS中使用MCS时,仔细选择患者至关重要.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 带有心脏性休克的急性心肌梗塞 (AMICS) 是一种高死亡率的疾病.
- 对于AMICS的干预措施是使用尽管边际好处和潜在的危害.
- 医疗保健系统创造了用于分析干预结果的自然实验.
研究的目的:
- 在AMICS患者中,比较机械循环支持 (MCS) 与大动脉内气球逆脉冲 (IABP) 的临床结果.
- 分析与不同AMICS干预相关的死亡率和并发症率.
主要方法:
- 在一个大型卫生系统中使用临床注册数据的观察性研究.
- 对30天和180天死亡率,严重出血和进入部位损伤的分析.
- 多变量逻辑回归用于比较MCS和IABP组之间的结果.
主要成果:
- 在AMICS中使用MCS与明显更高的30天和180天死亡风险有关.
- 与IABP倾向的医院相比,MCS倾向的医院显示出较高的180天死亡率和出血率.
- 在MCS中观察到增加30天死亡率和访问部位损伤的趋势.
结论:
- 机械循环支持 (MCS) 对于AMICS的使用与现实环境中的并发症增加有关.
- 临床医生必须在AMICS中适用MCS的严格选择标准,以优化益处并最大限度地减少危害.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.1K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.5K
相关概念视频
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care
528
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.7K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K
